Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Panacea Biotec Limited ( (IN:PANACEABIO) ) has shared an announcement.
Panacea Biotec Limited announced key changes in its leadership, with Mr. Vinod Goel appointed as the new Chief Financial Officer and Mr. Ankit Jain as the Company Secretary and Compliance Officer. These appointments, effective December 16, 2025, follow the resignation of the previous CFO, Mr. Devender Gupta. Additionally, the company has revised its policy for determining the materiality of events and authorized specific personnel for disclosures to stock exchanges, which may enhance its governance and operational transparency.
More about Panacea Biotec Limited
Panacea Biotec Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of vaccines, biopharmaceuticals, and other healthcare products. The company is engaged in providing innovative healthcare solutions and has a market presence in both domestic and international sectors.
Average Trading Volume: 7,931
Technical Sentiment Signal: Buy
Current Market Cap: 22.22B INR
Find detailed analytics on PANACEABIO stock on TipRanks’ Stock Analysis page.